Journal of Endocrinological Investigation

, Volume 28, Issue 11, pp 810–814 | Cite as

The vitamin D receptor fokl start codon polymorphism and bone mineral density in male hypogonadotrophic hypogonadism

  • S. E. Bolu
  • F. E. Orkunoglu Suer
  • F. Deniz
  • G. Ückaya
  • N. Imirzalioglu
  • M. Kutlu
Original Articles


The genetic factors determining bone mineral density (BMD) are not well characterized. Many studies have investigated the relationship between the fokl polymorphism of vitamin D receptor (VDR) gene in diverse populations and gender, resulting in conflicting outcomes. Because peak bone mass in men is closely related to sufficient androgen release, the contribution of VDR gene on BMD might have been masked by hormonal status of adulthood. We therefore investigated the relationship between the fokl polymorphism of VDR and BMD in male patients with idiopathic hypogonadotrophic hypogonadism (IHH). Sixty-five untreated male patients with IHH and 39 healthy matched controls were evaluated. fokl polymorphism (“f” allele) was detected by polymerase chain reaction (PCR)-restriction fragment length polymorphism using restriction endonuclease fokl, and BMD was measured by dual Energy X-ray absorpsiometry in lumbar spine, femur and radius. The distribution of FF, Ff, and ff alleles in patients with IHH and controls were not different (patients; 46%, 51%, 3% and controls; 51.3%, 46.1%, 2.6%, respectively). BMD levels in patients with IHH were significantly lower than controls. We categorized patients and control subjects in subgroups according to whether they had homozygous FF and heterozygous Ff genotype. No differences in BMD were seen between control subgroups, but total femur and femoral neck BMD were significantly lower in patients bearing heterozygous Ff genotype with IHH than homozygous FF ones (p=0.017 and p=0.009, respectively). Ff genotype might run down the BMD in cortical bone of femur, which needs to be proved in further studies.


Bone mineral density hypogonadism fokl vitamin D receptor polymorphism osteoporosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Hobson EE, Ralston SH. The genetics of osteoporosis. Endocrinologist 1997, 7: 429–35.CrossRefGoogle Scholar
  2. 2.
    Mundy GR. Osteoporozis: boning up on genes. Nature 1994, 367: 216–7.PubMedCrossRefGoogle Scholar
  3. 3.
    Pocock NA, Eisman JA, Hopper JL, et al. Genetic determinants of bone mass in adults: a twin study. J Clin Invest 1987, 80: 706–10.PubMedCentralPubMedCrossRefGoogle Scholar
  4. 4.
    Kelly PJ, Nguyen TV, Hopper J, Pocock NA, Sambrook PN, Eisman JA. Changes in axial bone density with age: a twin study. J Bone Miner Res 1993, 8: 11–7.PubMedCrossRefGoogle Scholar
  5. 5.
    Mundy GR. The genetics of osteoporosis. Endocrinologist 1995, 5: 176–9.CrossRefGoogle Scholar
  6. 6.
    Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV. Prediction of bone density from vitamin D receptor alleles. Nature 1994, 367: 284–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Fleet JC, Harris SS, Wood RJ, Dawson-Huges B. The Bsml vitamin D receptor restriction fragment polymorphism (BB) predicts low bone density in postmenopausal black and white woman. J Bone Miner Res 1995, 10: 985–90.PubMedCrossRefGoogle Scholar
  8. 8.
    Spector TD, Keen RW, Arden NK, Morrison NA, Major PJ, Nguyen TV. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women: a twin study in Britain. BMJ 1995, 310: 1357–60.PubMedCentralPubMedCrossRefGoogle Scholar
  9. 9.
    Riggs BL, Nguyen TV, Melton LJ, et al. The contribution of vitamin D receptor alleles to determination of bone mineral density in normal and osteoporotic women. J Bone Miner Res 1995, 10: 991–6.PubMedCrossRefGoogle Scholar
  10. 10.
    Barger-Lux MJ, Heaney RP, Hayes J, DeLuca HF, Johnson ML, Gong G. Vitamin D receptor polymorphism, bone mass, body size and vitamin D receptor density. Calcif Tissue Int 1995, 57: 161–2.PubMedCrossRefGoogle Scholar
  11. 11.
    Viitanen AM, Karkkainen M, Laitinen K, et al. Common polymorphism of the vitamin D receptor gene is associated with variation of peak bone mass in young Finnish population. Calcif Tissue Int 1996, 59: 231–4.PubMedCrossRefGoogle Scholar
  12. 12.
    Houston LA, Grant SFA, Reid DM, Ralston SH. Vitamin D polymorphism, bone mineral density, and osteoporotic vertebral fracture: studies in a UK population. Bone 1996, 18: 249–52.PubMedCrossRefGoogle Scholar
  13. 13.
    Salamone LM, Ferrel R, Black DM, Palermo L, Epstein RS, Petro N. The association between vitamin D receptor gene polymorphism and bone mineral density at the spine, hip and whole-body in premenopausal women. Osteoporos Int 1996, 6: 63–68 and 187–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Uitterlinden AG, Pols HAP, Burger H, et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphism with bone mineral density. J Bone Miner Res 1996, 11: 1241–8.PubMedCrossRefGoogle Scholar
  15. 15.
    Alahari KD, Lobaugh B, Econs MJ. Vitamin D receptor alleles do not correlate with bone mineral density in premenopausal Caucasian women from the southeastern United States. Metabolism 1997, 46: 224–6.PubMedCrossRefGoogle Scholar
  16. 16.
    Jorgenstein HL, Scholler J, Sand JC, Bjuring M, Hassager C, Christiansen C. Relation of common allelic variation at vitamin D receptor locus to bone mineral density and postmenopausal bone loss: cross-sectional and longitudinal population study. BMJ 1996, 313: 586–90.CrossRefGoogle Scholar
  17. 17.
    Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 1996, 11: 1850–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Aria H, Miyamoto KI, Takenani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effects on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997, 12: 915–21.CrossRefGoogle Scholar
  19. 19.
    Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA. Vitamin D receptor gene Fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 1999, 14: 740–6.PubMedCrossRefGoogle Scholar
  20. 20.
    Ferrari S, Manen D, Bonjour JP, Slosman D, Rizzoli R. Bone mineral mass and calcium and phosphate metabolism in young men: relationship with vitamin D receptor allelic polymorphism. J Clin Endocrinol Metab 1999, 84: 2043–8.PubMedGoogle Scholar
  21. 21.
    Strandberg S, Nordstorm P, Lorentzon R, Lorentzon M. Vitamin D receptor start codon polymorphism (Fok1) is related to bone mineral density in healthy adolescent boys. J Bone Miner Metab 2003, 21: 109–13.PubMedCrossRefGoogle Scholar
  22. 22.
    Chiu KC, Chuang LM, Yoon C. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001, 2: 2.PubMedCentralPubMedCrossRefGoogle Scholar
  23. 23.
    Kanan RM, Varanasi SS, Francis RM, Parker L, Datta HK. Vitamin D receptor gene start codon polymorphism (Fokl) and bone mineral density in healthy male subjects. Clin Endocrinol (Oxf) 2000, 53: 93–8.CrossRefGoogle Scholar
  24. 24.
    Ozisik G, Mengen H, Ozata M, et al. Vitamin d-receptor gene polymorphism and vertebral bone density in men with idiopathic hypogonadotrophic hypogonadism. Med Sci Monit 2001, 7: 233–7.PubMedGoogle Scholar
  25. 25.
    Finkelstein JS, Klinbanski A, Neer RM. Increases in bone density during treatment of men with hypogonadotrophic hypogonadism. J Clin Endocrinol Metab 1989, 367: 284–7.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2005

Authors and Affiliations

  • S. E. Bolu
    • 1
  • F. E. Orkunoglu Suer
    • 2
  • F. Deniz
    • 1
  • G. Ückaya
    • 1
  • N. Imirzalioglu
    • 3
  • M. Kutlu
    • 1
  1. 1.Department of Endocrinology and MetabolismGulhane Military Medical AcademyAnkaraTurkey
  2. 2.Department of ImmunologyGulhane Military Medical Academy, School of MedicineAnkaraTurkey
  3. 3.Department of Medical GeneticsGulhane Military Medical Academy, School of MedicineAnkaraTurkey

Personalised recommendations